Liver Cancer

Journal Title：Liver Cancer

Liver cancer has a very high prevalence among cancers in general and is one of the most common causes of death worldwide. Based on these facts, the journal ‘Liver Cancer’ serves the growing need to better understand the causes, mechanisms and therapy of the malignancy. It provides the international community of researchers and clinicians with a platform for their research results, focusing on molecular carcinogenesis, prevention, surveillance, diagnosis and treatment, including molecular targeted therapy, of the disease. 'Liver Cancer' publishes clinical and translational research related to the field of liver cancer in both humans and experimental models in the form of original and review articles.

肝癌在癌症中发病率极高，是全球最常见的死亡原因之一。基于这些事实，《肝癌》杂志满足了人们日益增长的需求，让人们更好地了解这种恶性肿瘤的病因、机制和治疗方法。它为国际研究人员和临床医生提供了一个平台，展示他们的研究成果，重点关注该疾病的分子致癌作用、预防、监测、诊断和治疗，包括分子靶向治疗。《肝癌》以原创和评论文章的形式发表与人类和实验模型肝癌领域相关的临床和转化研究。

Liver Cancer创刊于2012年，由S. Karger AG出版商出版，收稿方向涵盖Oncology - Medicine全领域，在行业领域中学术影响力很大，属于国际一流期刊，关注度和专业度非常高，所以对原创文章要求创新性很高，过审难度很高，如果您有志于一流期刊，建议关注此刊。平均审稿速度 16 Weeks ，影响因子指数11.6，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。